Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its...

Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) has a valuation score of 85/100 (strong), profitability score of 62/100 (moderate), financial health score of 67/100 (moderate), Piotroski F-Score of 5/9, Altman Z-Score of 1.75 (distressed), revenue growth of +1.0% YoY.

Neutral

Analyst Consensus

Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations30 analysts · 2026-08-01
7
10
12
Strong Buy 7Buy 10Hold 12Sell 1Strong Sell 0
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Valuation & P/E History →Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →